Clinical Trial Update: Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types [Phase 1, Phase 2]

View source ↗

Summary

This update reports a Phase 1/2 trial of atezolizumab plus tivozanib in several immunologically cold tumor types, with the study currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bile Duct Cancer
• Breast Cancer
• Gallbladder Cancer
• Neuroendocrine Tumor
• Ovarian Cancer
• Pancreatic Adenocarcinoma
• Prostate Cancer
• Soft Tissue Sarcoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Tivozanib (tivozanib)

Snippet

Sponsor: University of Florida | Conditions: Bile Duct Cancer, Gall Bladder Cancer | Phase 1, Phase 2 | Status: SUSPENDED